Jeff Evanson, Chief Commercial Officer: Outlook Therapeutics OTLK Buy · Filed 24/03/11

Trade details

Type: Insider buy
Amount: $26,243.28
Shares · price: 62,484 sh · $0.42 a share
Held after: 808,459 sh
Stock: Outlook Therapeutics OTLK
Person: Jeff EvansonChief Commercial Officer
Trade date: 24/03/07
Filed: 24/03/11
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +8.4%

Outlook Therapeutics trades, last 26 weeks

What else happened in Outlook Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/06~24/04/06

Jeff Evanson's recent trades

Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$296.4K
267,000 sh
$296.4K
Filed 23/01/24
Traded 23/01/20
Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$126K
103,255 sh
$126K
Filed 23/01/19
Traded 23/01/19
Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$42.2K
33,738 sh
$42.2K
Filed 23/01/19
Traded 23/01/18
Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$35.6K
27,162 sh
$35.6K
Filed 23/01/19
Traded 23/01/17